Sematide 0.25mg Pfs Prefilled Syringe
Semaglutide 0.25mg prefilled syringe for type 2 diabetes.
Sematide 0.25mg Pfs Prefilled Syringe contains semaglutide, a GLP-1 receptor agonist for type 2 diabetes and/or weight management. The 0.25mg dose is for weekly subcutaneous injection during initiation. Use only as directed by your doctor.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise; may be used for weight management when prescribed.
Ingredients
Semaglutide 0.25mg per prefilled syringe; formulation as per pack.
Warnings
Contraindicated in personal or family history of medullary thyroid cancer and in pregnancy. Risk of pancreatitis. Report severe abdominal pain. Not for type 1 diabetes.
Side Effects
Nausea, vomiting, diarrhoea, abdominal pain, constipation. Rare: pancreatitis, gallbladder disease. Report severe abdominal pain or persistent vomiting.
Storage Instructions
Store in refrigerator before first use; may be kept at room temperature for period stated. Protect from light. Do not freeze. Use within period after first use.
| Brand | Ferozsons |
| Status | Active |